Results for tag: "CETP Inhibitor"

The CETP Inhibitor market is a segment of the Cardiovascular Drugs market. CETP Inhibitors are drugs that inhibit the cholesteryl ester transfer protein (CETP) enzyme, which is responsible for the transfer of cholesterol from high-density lipoprotein (HDL) to low-density lipoprotein (LDL). By inhibiting CETP, these drugs can help reduce LDL cholesterol levels and increase HDL cholesterol levels, which can reduce the risk of cardiovascular disease. CETP Inhibitors are typically prescribed to patients with high cholesterol levels who are unable to control their cholesterol levels with diet and exercise alone. Some companies in the CETP Inhibitor market include Merck, Pfizer, Sanofi, and Eli Lilly. Show Less Read more